A new study suggests Paxlovid may not reduce the risk of covid-19 hospitalizations and all-cause deaths in vaccinated adults ...

(HealthDay News) — Individuals previously hospitalized for COVID-19 have an increased risk for subsequent death or hospitalization for various organ disorders up to 30 months after discharge, ...

The antiviral pill Paxlovid does not significantly reduce COVID-19 hospitalizations in vaccinated older adults, according to ...

A French nationwide study has revealed that survivors of COVID-19 hospitalization face an increased risk of death or ...

Researchers have found in a new study that among COVID-19 patients with asthma, those who received Paxlovid had a ...

Fuchs wishes more people would come to her with their worries about vaccine safety and side effects. Most people, she said, ...

Utahns and Utah's health leaders have learned quite a bit about infectious diseases and how to respond in the five years ...

COVID is still circulating in hospitals, according to Dr. Ken Lyn-Kew of National Jewish, but fewer are getting severely sick ...

A major study published in Infectious Diseases reveals that older COVID-19 hospitalization survivors face elevated health risks lasting up to two and a half years after discharge.

“Findings in this report show that vaccination with the 2024–2025 influenza vaccine reduced the likelihood of medically attended influenza and support CDC’s recommendation that all persons aged ≥6 ...

Risks notably higher for neurological, respiratory, renal, and diabetes-related conditions, say researchers - Anadolu Ajansı ...

Even with recommendations in place, hospitals were far from uniform in their anticoagulation approaches well into 2022.